Sector: MedicalNXSTAGE MEDICAL INC (NASDAQ: NXTM)
Ranking History
Scan Date: | 11/24/2009 |
Sector: | Medical |
Funamental : | 236 |
Technical : | 23 |
Performance : | 138 |
Overall: | 113 |
Number of Stocks: | 308 |
Scan Date: | 11/17/2009 |
Sector: | Medical |
Funamental : | 236 |
Technical : | 125 |
Performance : | 144 |
Overall: | 191 |
Number of Stocks: | 307 |
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 242 |
Technical : | 94 |
Performance : | 141 |
Overall: | 178 |
Number of Stocks: | 306 |
Headlines
- NxStage(R) Reports Third Quarter 2009 Financial Results and Raises Revenue Guidance for Fiscal 2009
Nov 05, 2009 07:09 AM | NXTM
- NxStage(R) Reports Significant Interim FREEDOM Study Results
Oct 27, 2009 08:03 AM | NXTM
- NxStage(R) to Report Third Quarter 2009 Financial Results
Oct 15, 2009 12:53 PM | NXTM
- Boston Business Journal Names NxStage(R) Medical Third Fastest Growing Company in Massachusetts
Oct 01, 2009 08:02 AM | NXTM
- NxStage Patient Takes Dialysis Machine on Third Annual Patient Good-Will Tour
Sep 18, 2009 04:32 PM | NXTM
- NxStage(R) Announces Streamline(R) Blood Tubing Set Supply Agreement Between Medisystems(R) and Reliant Renal Care
Sep 14, 2009 04:22 PM | NXTM
- NxStage to Present at the UBS Global Life Sciences Conference
Sep 01, 2009 04:35 PM | NXTM, UBS
- SmallCapSentinel.com: Going International
Aug 28, 2009 07:01 AM | ISRG, MDT, NXTM, VAR
- Modest Rise From Small Caps
May 21, 2009 01:03 PM | AIG, BAC, GS, IGLD, MCD, NXTM
- Earnings Preview For Nov 3 - 7 - Earnings Preview
Oct 31, 2008 10:03 PM | ABCO, ABD, ACW, ADES, AEE, AER
- Midday P&L Statement: Medifast Revenues up 26%; Medallion Financial Q4 Income Up 76%; Gramercy Capital Revenues Up $287 million; Raven Industries Sales Up 20%; NxStage Reports Record Revenue; Caliper Life Sciences Reports Loss
Mar 12, 2009 02:00 PM | CALP, GKK, MED, NXTM, RAVN, TAXI
- Midday P&L Statement: Medifast Revenues up 26%; Medallion Financial Q4 Income Up 76%; Gramercy Capital Revenues Up $287 million; Raven Industries Sales Up 20%; NxStage Reports Record Revenue; Caliper Life Sciences Reports Loss
Mar 12, 2009 02:00 PM | CALP, GKK, MED, NXTM, RAVN, TAXI
- NxStage Reports Second Quarter 2009 Financial Results
Aug 05, 2009 07:52 AM | DVA, HSIC, NXTM
- NxStage to Present at the Canaccord Adams Global Growth Conference
Jul 31, 2009 08:01 AM | NXTM
- NxStage(R) Announces Extension of Medisystems Needle Supply and Distribution Agreement
Jul 21, 2009 08:02 AM | NXTM
- NxStage to Report Second Quarter 2009 Financial Results
Jul 20, 2009 09:07 AM | NXTM
- NxStage(R) Announces Medisystems(R) Bloodline Distribution Agreement with Gambro
Jun 17, 2009 08:34 AM | NXTM
- NxStage Announces Closing of $40 Million Debt Financing with Asahi Kasei Kuraray Medical
Jun 05, 2009 04:09 PM | NXTM
- NxStage Extends Supply Agreement with B. Braun Medical Inc. to Include Streamline(R) Technology
Jun 01, 2009 08:38 AM | NXTM
- NxStage Medical Signs Transportation Services Contract With Transplace
May 27, 2009 10:57 AM | NXTM
- NxStage Announces Strategic Business Alliance with Asahi Kasei Kuraray Medical
May 18, 2009 04:08 PM | NXTM
- NxStage Ranked Fourth Largest Revenue Gaining Company in Massachusetts for 2008
May 14, 2009 09:54 AM | NXTM
- Form 4 DEERFIELD INTERNATIONAL For: Oct 09 (10K)
Oct 13, 2009 07:58 PM
- Form 4 DEERFIELD INTERNATIONAL For: Sep 29 (10K)
Oct 01, 2009 07:26 PM
- Form 4 DEERFIELD INTERNATIONAL For: Sep 21 (10K)
Sep 23, 2009 08:06 PM
- Form 4 DEERFIELD INTERNATIONAL For: Sep 17 (10K)
Sep 21, 2009 07:11 PM
- Form 4 DEERFIELD INTERNATIONAL For: Sep 11 (10K)
Sep 16, 2009 06:55 PM
- Form 4 REID PERPER For: Jun 30 (10K)
Jul 01, 2009 08:49 PM
- Form 4 NxStage Medical, Inc. For: Jun 30 Filed by: MOORE CRAIG W (10K)
Jul 01, 2009 08:49 PM
- Form 4 Giannini Daniel A For: Jun 30 (10K)
Jul 01, 2009 08:46 PM
- Form 4 Flynn James E For: Jun 12 (10K)
Jun 19, 2009 05:48 PM
- Form 4 NxStage Medical, Inc. For: May 28 Filed by: MOORE CRAIG W (10K)
Jun 01, 2009 06:14 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
NXTM
|
Compare to S&P
|
| YTD |
143.82 %
|
101.77 %
|
| 4 Weeks |
16.67 %
|
10.76 %
|
| 12 Weeks |
7.96 %
|
0.53 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 18.52 %
|
|
EPS Growth in Last Year: 24.14 %
|
|
Sales Growth in Last Quarter: 4.49 %
|
|
Sales Growth in Last Quarter: 24.84 %
|
|
